Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis
Patients with ischaemic cardiomyopathy receiving medical therapy in REVIVED-BCIS2 had better outcomes than those in STICHES, with or without CABG surgery. Further trials comparing CABG, PCI, and medical therapy in this population are warranted.
Authors
- Kieran F. Docherty (ORCID: https://orcid.org/0000-0002-5446-9969)
- Mark C. Petrie (ORCID: https://orcid.org/0000-0002-6333-9496)
- Eric J. Velazquez (ORCID: https://orcid.org/0000-0003-2245-7477)
- Guangyu Tong (ORCID: https://orcid.org/0000-0002-7697-5029)
- Divaka Perera (ORCID: https://orcid.org/0000-0001-6362-1291)
- Tim Clayton (ORCID: https://orcid.org/0000-0002-1266-3288)
- Alexandra J. Lansky
- Evangelos Kontopantelis (ORCID: https://orcid.org/0000-0001-6450-5815)
- Mamas A. Mamas (ORCID: https://orcid.org/0000-0001-9241-8890)
- M. J. Ryan (ORCID: https://orcid.org/0000-0001-8256-195X)
- Guillaume Marquis‐Gravel (ORCID: https://orcid.org/0000-0003-2965-1504)
- Matthew Dodd (ORCID: https://orcid.org/0000-0002-6207-6604)
- Jean L. Rouleau (ORCID: https://orcid.org/0009-0004-0592-8091)
Institutions
- St Thomas' Hospital (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Montreal Heart Institute (CA)
- University of Manchester (GB)
- British Heart Foundation (GB)
- Yale University (US)
- London School of Hygiene & Tropical Medicine (GB)
- St. Thomas Hospital (CA)
- NIHR Birmingham Biomedical Research Centre (GB)
- Keele University (GB)
- Université de Montréal (CA)
- University of Glasgow (GB)
Publication Details
- Journal
- European Heart Journal
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1093/eurheartj/ehaf080
- Citations
- 18
- Primary Topic
- Cardiac Structural Anomalies and Repair
- Type
- article
- Field-Weighted Citation Impact
- 36.12
Funders
- AstraZeneca
- Alexion Pharmaceuticals
- Abiomed
- National Institute for Health and Care Research
- British Heart Foundation
- Novo Nordisk
- National Heart, Lung, and Blood Institute